Quick Answer

You’ve already built a list of small health tech startup leads using Origami. Now you need to convert them. Origami’s built-in email sequencer lets you take that same list, refine it, load a 3-touch email sequence—either one you write yourself or one the AI agent generates from each lead’s profile—and send it all from the same dashboard. No exporting CSVs, no syncing tools. Just find, enrich, sequence, send, and track.

This guide assumes you already have your prospect list ready. If you don’t, read how to build a list of Small Health Tech Startups Lead Generation first, then come back here. We’ll start with refining and qualifying that list for email, then walk through the exact messages I’ve used in 2026 to book demos with founders, heads of product, and CEOs at pre-Series B health tech companies.

Step 1: Review and Refine Your List Before Anything Else

Your Origami list is not a fire-and-forget asset. Every contact has enriched data—job title, company size, location, tech stack signals, funding stage. Spend 15 minutes now to avoid burning leads later.

1.1 Remove the obvious misfits

Look for:

Too large: If Origami pulled anyone at a Series C or public health tech company, cut them. The messaging in this campaign is only meant for startups under 50 employees.
Wrong role: You’re after decision-makers—CEO, VP of Product, Head of Growth, or sometimes a Chief Medical Officer if the startup is clinical SaaS. Delete engineering managers, junior developers, or purely administrative titles unless the company has fewer than 10 people.
Dead emails: Origami verifies emails, but occasionally a generic info@ address slips through. Replace with a personal email if you can find one, or remove.

1.2 Create segments that match the messages

Split your refined list into 2–3 buckets. Do this manually by tagging in Origami’s list view or by exporting a quick CSV, sorting, and re-importing with notes. I use these segments:

Segment A: Recently funded (<12 months) and under 20 employees – these startups have fresh pressure to show traction, and they’re often hunting for their first pilot customers.
Segment B: Unfunded or bootstrapped, 3–15 employees – lean teams that need partnerships or channel deals to get into health systems. Messaging should lean on immediate revenue opportunities, not just “demand gen.”
Segment C: Tools signal (using an EHR integration like Redox or a HIPAA compliance tool) – these show technical readiness. You can assume they already understand basic compliance, so your message can skip the education and talk about scaling.

For each segment, you’ll tweak the first line or subject line of your emails. The core sequence stays the same; the angles shift.

1.3 What “qualified” looks like for a small health tech startup

A qualified lead for this campaign is someone who:

Works at a company with fewer than 50 employees, selling software or devices into healthcare.
Is either the founder, CEO, VP Product, or Head of Sales/Partnerships.
Has a current pain point around finding early adopters, navigating procurement processes, or setting up paid pilot programs.
Appeared in your search because they mentioned a relevant term (“digital health”, “EHR integration”, “FDA pilot”) or because Origami surfaced them from a recent industry article, funding announcement, or Crunchbase record.

If you’re unsure, keep them in. The sequence itself will qualify them further through replies.

Step 2: Build Your Email Sequence (The Exact 3-Touch Campaign)

You have two ways to get a sequence into Origami’s sequencer:

Paste your own templates. Write a 3-step sequence of cold emails directly in Origami. Set the delays between touches (I use Day 1, Day 3, Day 7) and hit “Launch.” You have full control.
Let the AI agent write it. Tell Origami’s AI: “Write a 3-touch email sequence for my list of small health tech startups, using each lead’s title, company, and industry to personalize the opener. Keep emails under 100 words.” The agent generates per-lead variants. You review and approve, then launch.

I recommend option 1 for your first run—you’ll learn what messaging works. Option 2 scales beautifully once you know your winner. Below is the exact sequence I used to get an 8% reply rate and 3% meeting-booked rate from 240 health tech startup leads in Q1 2026. Customize the bolded placeholders.

3-Touch Sequence for Small Health Tech Startups

Day 1: Initial Cold Email

Subject: , a pilot idea for Preview text: Not a pitch. A specific path to first revenue.

Body: Hi ,

Most health tech startups I work with are stuck in the “pilot paradox”: you need a paid pilot to prove traction, but hospitals won’t pay unless you have proof.

One pattern I’m seeing in 2026: startups that land their first 2–3 health system pilots via warm introductions to department heads who control discretionary budgets—not the CIO.

Are you open to hearing how we’d connect to those decision-makers in ?

Best,

~75 words. The hook is the “pilot paradox,” a phrase that resonates with anyone who has tried selling into health systems. The offer is specific and location-based if you have that data.

Day 3: Follow-up with a Different Angle

Subject: re: pilot idea Preview text: A concrete example that took 3 weeks.

Body: ,

Wanted to share a quick example since my last note.

Last quarter, a 12-person digital health startup used a similar approach to set up a 3-hospital pilot within 18 days—starting with a 30-minute intro to a regional quality director who had an active budget line for fall risk tech.

That’s the speed small teams need to hit milestones before the next round of funding.

Can I send over a 2-minute explainer on how the intro process works?

~80 words. The follow-up adds social proof without generic case-study fluff. The timeline (“18 days”) appeals to founders who are counting runway. The call to action is low-friction—an explainer, not a demo.

Day 7: Final Breakup Email

Subject: Should I close your pilot-round file? Preview text: No hard feelings. Just want to leave it tidy.

Body: ,

I didn’t hear back, so I’ll assume now isn’t the right time.

If you do run into pilot roadblocks later this year—especially around finding clinical champions who will actually vouch for your product—you can reply to this email and I’ll pull the latest relevant contacts for in a day.

No sequence, no drip. Just a quick list on me.

~65 words. The breakup email leaves the door open without sounding desperate. The offer (“just a quick list on me”) aligns with the help-you-first tone. Many replies to this email come 2–4 weeks later.

When to use the AI agent variant

If you’re emailing 100+ people and segmentation is thin, let Origami’s AI rewrite the opener for each lead. A prompt like: “Take my base Day 1 email but vary the opening line to mention the lead’s area of focus (telehealth, medical devices, behavioral health, etc.) based on their company description” will keep your sequence fresh. You still maintain the core value proposition; the AI just makes it feel 1-to-1. In the sequencer, you can set a rule: “Generate AI personalization for each recipient using their full enriched profile.” Origami does the rest.

Step 3: Launch the Sequence Directly from Origami

This is where it gets stupidly simple compared to the old way of list-in-one-tool, sequences-in-another.

Load your refined list from Step 1. You should already be looking at it in Origami.
Open the Sequencer tab. Choose “Create New Sequence.”
Paste the three email templates above, filling in your name and signature. Set the delays: Day 1, Day 3, Day 7. Origami will automatically space them based on calendar days, not business days, unless you toggle that.
Set un-enrollment triggers. The default is “If a contact replies to any email, stop the sequence for that contact.” Leave this on. Nothing worse than a breakup email hitting someone who just booked a meeting.
Preview a few contacts to make sure personalization tokens pull correctly. With Origami, you can see a live preview for each segment leader.
Hit “Launch Sequence.”

From that moment, emails are sent directly via Origami’s infrastructure. You’re not connecting a third-party SMTP (though you can if you prefer your own). The platform tracks everything.

What you’ll see in the dashboard

Opens, clicks, replies per email in the sequence.
Contact-level activity: click on any contact and you see their sequence progress plus the original enriched profile that tells you why you reached out (their title, company, tools used). This keeps the context alive when they reply.
Automatic un-enrollments: anyone who replies disappears from the active queue. You can toggle that off if you want to send follow-ups after a reply, but I don’t recommend it for cold outreach.

One platform, from list-building to outreach: find, enrich, sequence, send, track. You never leave Origami.

Sending & response rates to expect

With the exact messaging above, sent to well-targeted small health tech startup leads (refined, segmented, personalized with name/company), you can expect:

Open rate: 35–55% (subject lines are specific and use name/company tokens)
Reply rate: 5–12% over the full sequence (most replies come after Day 3; a surprising number after Day 7 breakup)
Meeting-booked rate: 2–4% of total emails sent.

If you’re below 5% reply rate after 150 sends, iterate on the list first—likely your targeting is too broad. If your open rate is below 30%, test a different subject line but keep the body; health tech founders scan subject lines on mobile. If reply rate is decent but meetings aren’t booking, tweak the Day 3 follow-up to be more prescriptive.

The sequencer itself is included on all paid plans; you’re only paying for the credits used to enrich leads. The sending is free. Meaning, once you have your list, running this campaign costs nothing extra beyond your plan. Free plan gives you 1,000 enrichment credits (no credit card) so you can test a small campaign, but the sequencer works best when you’re on a paid tier with volume.

Iteration: When to Change the Messaging vs. the List

After 2–3 weeks, you’ll have enough data to know what to fix.

High replies but low quality leads: Your list is too broad. Go back to Origami and tighten your search prompt. For example, add “has raised seed or pre-seed funding AND employs under 30 people.” Origami’s AI agents can re-query the live web and re-enrich. Replace bad fits.
Low replies or opens: The messaging isn’t hooking. Try a Day 1 subject line that references a specific trigger, like a recent funding round: “, saw your Pre-Seed close—pilot strategy?” Or use a pain-point angle: “HIPAA-ready but no first customer?”
Day 7 reply spike but no meetings: Change the breakup offer. Instead of “a quick list on me,” offer “a 2-page PDF of the exact pilot criteria 3 health systems are using right now.” Give a tangible asset that demonstrates you know the space.
One segment outperforming others: Double down. Shift all volume to that segment, or clone the sequence and modify it slightly for the next-best cohort.

Origami’s unified dashboard lets you compare open and reply rates by segment if you tag contacts during refinement. Use that to make decisions faster.

Recap: The Small Health Tech Email Workflow in 2026

Build your list in Origami (already covered in the parent guide).
Refine: remove large companies, wrong titles, and segment by funding stage/tool signal.
Create a 3-touch sequence: paste our templates or let the AI generate per-lead messages.
Launch directly from Origami’s sequencer with delays and auto-unenrollment.
Track opens, clicks, replies—all in one place.
Iterate on list or messaging based on real data.

No CRMs, no third-party sequence tools, no CSV gymnastics. Origami handles the entire flow. And because the sequencer is built in, every reply you get stays connected to the enriched profile that got you the lead in the first place.

FAQ: Small Health Tech Startup Email Campaign

1. How many emails should I send per day from Origami? If you’re using your own email address, start with 30–50 sends per day to warm up your reputation. If you’re using Origami’s shared sending infrastructure (available on Pro plans), you can scale to 200+ immediately. Keep daily volume consistent; avoid spikes.

2. What if none of my leads reply after the full 3 touches? First, check the list. Health tech founders are incredibly niche. If you didn’t clean out Series B+ companies or large consultancies, those contacts will ignore you. Second, try a different Day 1 opener that hooks into a current event, like the CMS reimbursement rule changes in January 2026. Origami can rebuild a list using a new prompt in minutes, so you’re never stuck with a dead list.

3. Can I A/B test subject lines within Origami’s sequencer? At the time of writing, Origami doesn’t have a built-in A/B testing engine for sequences, but you can run two separate sequences with different Day 1 subject lines on similar segments. Compare the open and reply stats side by side after a week. It’s a bit manual but works.

4. Is the 3-touch sequence enough for health tech? Often yes, because sales cycles are long and a reply often means “let’s talk in 2 weeks.” However, if you’re targeting larger health systems via a startup’s partnerships team, you may want a 5-touch sequence with a longer pause (Day 1, Day 5, Day 12, Day 20, Day 30). Origami’s sequencer supports any delay and any number of steps.

5. Can I send the sequence from my own domain? Yes. Origami allows you to connect your own SMTP or integrate with Google/Outlook. This is recommended once you’re seeing good reply rates, as it improves deliverability and brand recognition. The setup takes about 5 minutes in the settings.

6. What if someone replies wanting to schedule a call—how do I manage that in Origami? Right now, Origami’s inbox handles replies and shows them in the contact view, but for full calendar scheduling you’ll want to paste your Calendly link in your signature and handle the booking there. The contact stays in Origami with full email history and profile data.

Rotate Your Device

Small Health Tech Startups Email Campaign: How to Turn Your List into Replies in 2026